Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
FORUM MARKETS Inc: Filed Certificate of Designations for Series B Convertible Preferred Stock, designating 1,000,000 shares with specific voting, dividend, liquidation, and conversion rights (effective 2024-09-30).
- Change
- charter amendment
- Effective
- 2024-09-30
Exact text from the filing
On September 30, 2024, in contemplation of the closing of the transactions contemplated by the Purchase Agreement, and pursuant to the power provided to the Company by the Certificate of Incorporation of the Company, as amended, the Company’s Board of Directors approved the adoption of, and filing of, a Certificate of Designations of 180 Life Sciences Corp. Establishing the Designations, Preferences, Limitations and Relative Rights of Its Series B Convertible Preferred Stock (the “ Series B Designation ”), which was filed with, and became effective with, the Secretary of State of Delaware on the same date.
View on SEC.gov
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
FORUM MARKETS Inc completed an acquisition involving Elray Resources, Inc. for 1,000,000 shares of newly designated Series B Convertible Preferred Stock and warrants to purchase 3,000,000 shares of common stock (closed 2024-09-30).
- Action
- acquisition
- Counterparty
- Elray Resources, Inc.
- Consideration
- 1,000,000 shares of newly designated Series B Convertible Preferred Stock and warrants to purchase 3,000,000 shares of common stock
- Closing
- 2024-09-30
Exact text from the filing
Purchase Agreement, Elray agreed to sell us certain source code and intellectual property relating to an online blockchain casino (the “ Purchased Assets ”) in consideration for 1,000,000 shares of newly designated Series B Convertible Preferred Stock (the “ Preferred Stock ”, and the shares of common stock issuable upon conversion thereof, the “ Conversion Shares
View on SEC.gov